Chargement en cours...

Pazopanib and Statin-Induced Rhabdomyolysis

BACKGROUND: The VEGF inhibitor pazopanib is a widely used first-line therapy for the treatment of advanced renal cell carcinoma. Potential drug-drug interactions and toxicities may be underrecognized. CASE PRESENTATION: A 73-year-old woman with metastatic renal cell carcinoma on treatment with pazop...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Case Rep Oncol
Auteurs principaux: Logue, Jennifer M., Kiani, Bahram, Bitting, Rhonda L.
Format: Artigo
Langue:Inglês
Publié: S. Karger AG 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731169/
https://ncbi.nlm.nih.gov/pubmed/29279698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000481659
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!